FGFR
FGFRs (fibroblast growth factor receptors) are transmembrane tyrosine kinase receptor. It is involved in carcinogenesis and plays an important role in cell differentiation, survival and proliferation etc.
Products Related to FGFR(109)
- GC16732TSU-68 (SU6668,Orantinib)CAS: 252916-29-3Purity: >98.50%
TSU-68 (SU6668,Orantinib) (SU6668; TSU-68) is a multi-targeted receptor tyrosine kinase inhibitor with Kis of 2.1 μM, 8 nM and 1.2 μM for Flt-1, PDGFRβ and FGFR1, respectively.
- GC19142ErdafitinibCAS: 1346242-81-6Purity: >99.50%
Erdafitinib is an orally available, selective tyrosine kinase inhibitor of the entire FGFR family (FGFR1: IC 50 = 1.2nM; FGFR2: IC 50 = 2.5nM; FGFR3: IC 50 = 3.0nM; FGFR4: IC 50 = 5.7nM).
- GC19154RoblitinibCAS: 1708971-55-4Purity: >99.00%
Roblitinib is an orally active fibroblast growth factor receptor 4 (FGFR4) antagonist (IC 50 =1.9nM).
- GC19155FGFR4-IN-1CAS: 1708971-72-5Purity: >99.50%
FGFR4-IN-1 is a potent inhibiotr of FGFR4 with IC50 of 0.7 nM.
- GC19399DerazantinibCAS: 1234356-69-4Purity: >99.50%
Derazantinib is a novel, ATP competitive, small molecule, multi-kinase inhibitor with IC 50 of 1.8nM for FGFR2, and 4.5nM for FGFR1 and 3.
- GC30767Heparan SulfateCAS: 9050-30-0
Heparan Sulfate is a complex polyanionic polysaccharide, regulates important developmental processes in invertebrates and vertebrates.
- GC31495PF-05231023CAS: 1037589-69-7Purity: >98.00%
PF-05231023 is a long-acting fibroblast growth factor 21 (FGF21) analog.
- GC32127Alofanib (RPT835)CAS: 1612888-66-0Purity: >98.50%
Alofanib (RPT835) (RPT835) is a potent and selective allosteric inhibitor of fibroblast growth factor receptor 2 (FGFR2).
- GC32760Dovitinib lactate (CHIR-258 lactate)CAS: 692737-80-7Purity: >99.50%
Dovitinib lactate (CHIR-258 lactate) (TKI258 lactate) is a multi-targeted tyrosine kinase inhibitor with IC50s of 1, 2, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, FGFR1/3, VEGFR1/2/3 and PDGFRα/β, respectively.
- GC32805Sulfatinib (HMPL-012)CAS: 1308672-74-3Purity: >98.00%
Sulfatinib (HMPL-012) (HMPL-012) is a potent and highly selective tyrosine kinase inhibitor against VEGFR1/2/3, FGFR1 and CSF1R with IC50s of in a range of 1 to 24 nM.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC16327 | Pazopanib (GW-786034) | 444731-52-6 | >99.50% | |
A multi-kinase inhibitor | ||||
| GC16519 | ENMD-2076 | 934353-76-1 | >98.00% | |
A multi-kinase inhibitor | ||||
| GC16732 | TSU-68 (SU6668,Orantinib) | 252916-29-3 | >98.50% | |
TSU-68 (SU6668,Orantinib) (SU6668; TSU-68) is a multi-targeted receptor tyrosine kinase inhibitor with Kis of 2.1 μM, 8 nM and 1.2 μM for Flt-1, PDGFRβ and FGFR1, respectively. | ||||
| GC17323 | FIIN-2 | 1633044-56-0 | >99.50% | |
Irreversible inhibitor of FGFR | ||||
| GC17943 | PD173074 | 219580-11-7 | >98.00% | |
PD173074 is an ATP-competitive FGFR1 and VEGFR2 inhibitor with an IC 50 value of 26nM and 100-200nM, respectively, showing higher selectivity for FGFR1 over PDGFR and c-Src. | ||||
| GC19075 | BLU-554 | 1707289-21-1 | >99.50% | |
BLU-554 is a selective inhibitor of fibroblast growth factor receptor 4 (FGFR4) (IC 50 = 5nM). | ||||
| GC19142 | Erdafitinib | 1346242-81-6 | >99.50% | |
Erdafitinib is an orally available, selective tyrosine kinase inhibitor of the entire FGFR family (FGFR1: IC 50 = 1.2nM; FGFR2: IC 50 = 2.5nM; FGFR3: IC 50 = 3.0nM; FGFR4: IC 50 = 5.7nM). | ||||
| GC19154 | Roblitinib | 1708971-55-4 | >99.00% | |
Roblitinib is an orally active fibroblast growth factor receptor 4 (FGFR4) antagonist (IC 50 =1.9nM). | ||||
| GC19155 | FGFR4-IN-1 | 1708971-72-5 | >99.50% | |
FGFR4-IN-1 is a potent inhibiotr of FGFR4 with IC50 of 0.7 nM. | ||||
| GC19156 | TAS-120 | 1448169-71-8 | >98.00% | |
TAS-120 is a highly bioavailable, selective, and irreversible fibroblast growth factor receptor (FGFR) inhibitor that demonstrates potent inhibitory activity against FGFR1-4, with IC₅₀ values of 3.9nM, 1.3nM, 1.6nM, and 8.3nM. | ||||
| GC19187 | H3B-6527 | 1702259-66-2 | >98% | |
H3B-6527 (H3 Biomedicine) is a highly selective FGFR4 inhibitor with potent antitumour activity in FGF19 amplified cell lines and mice. | ||||
| GC19279 | PD-166866 | 192705-79-6 | >99.50% | |
PD-166866 is a selective and orally active FGFR1 (fibroblast growth factor receptor 1) tyrosine kinase inhibitor, with an IC₅₀ of 52.4nM. | ||||
| GC19317 | S49076 | 1265965-22-7 | >99.50% | |
S49076 is a novel, potent inhibitor of MET, AXL/MER, and FGFR1/2/3 with IC50 values below 20 nM. | ||||
| GC19341 | SUN11602 | 704869-38-5 | >98.00% | |
SUN11602 is a novel aniline compound with basic fibroblast growth factor-like activity. | ||||
| GC19399 | Derazantinib | 1234356-69-4 | >99.50% | |
Derazantinib is a novel, ATP competitive, small molecule, multi-kinase inhibitor with IC 50 of 1.8nM for FGFR2, and 4.5nM for FGFR1 and 3. | ||||
| GC30767 | Heparan Sulfate | 9050-30-0 | - | |
Heparan Sulfate is a complex polyanionic polysaccharide, regulates important developmental processes in invertebrates and vertebrates. | ||||
| GC31495 | PF-05231023 | 1037589-69-7 | >98.00% | |
PF-05231023 is a long-acting fibroblast growth factor 21 (FGF21) analog. | ||||
| GC32127 | Alofanib (RPT835) | 1612888-66-0 | >98.50% | |
Alofanib (RPT835) (RPT835) is a potent and selective allosteric inhibitor of fibroblast growth factor receptor 2 (FGFR2). | ||||
| GC32760 | Dovitinib lactate (CHIR-258 lactate) | 692737-80-7 | >99.50% | |
Dovitinib lactate (CHIR-258 lactate) (TKI258 lactate) is a multi-targeted tyrosine kinase inhibitor with IC50s of 1, 2, 8/9, 10/13/8, 27/210 nM for FLT3, c-Kit, FGFR1/3, VEGFR1/2/3 and PDGFRα/β, respectively. | ||||
| GC32802 | PRN1371 | 1802929-43-6 | >99.50% | |
An irreversible pan-FGFR inhibitor | ||||
| GC32805 | Sulfatinib (HMPL-012) | 1308672-74-3 | >98.00% | |
Sulfatinib (HMPL-012) (HMPL-012) is a potent and highly selective tyrosine kinase inhibitor against VEGFR1/2/3, FGFR1 and CSF1R with IC50s of in a range of 1 to 24 nM. | ||||
| GC32835 | PP58 | 212391-58-7 | >99.00% | |
PP58 is a pyrido[2,3-d]pyrimidine-based compound that inhibits PDGFR, FGFR and Src family activities with nanomolar IC50 values. | ||||
| GC32915 | Pemigatinib | 1513857-77-6 | >98.00% | |
An FGFR inhibitor | ||||
| GC33352 | CP-547632 | 252003-65-9 | >98.50% | |
A potent inhibitor of VEGFR2 and bFGF | ||||
